These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30335850)

  • 1. Pathogen-based precision medicine for drug-resistant tuberculosis.
    Gröschel MI; Walker TM; van der Werf TS; Lange C; Niemann S; Merker M
    PLoS Pathog; 2018 Oct; 14(10):e1007297. PubMed ID: 30335850
    [No Abstract]   [Full Text] [Related]  

  • 2. Lesion Heterogeneity and Long-Term Heteroresistance in Multidrug-Resistant Tuberculosis.
    Chen Y; Ji L; Liu Q; Li J; Hong C; Jiang Q; Gan M; Takiff HE; Yu W; Tan W; Gao Q
    J Infect Dis; 2021 Sep; 224(5):889-893. PubMed ID: 34467983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intercontinental translocation of latent multidrug-resistant tuberculosis to Australia demonstrated by whole genome sequencing.
    Gautam SS; Haug G; Cooley LA; Mac Aogáin M; O'Toole RF
    Med J Aust; 2019 Mar; 210(5):236-236.e1. PubMed ID: 30793313
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-resistant tuberculosis.
    Böttger EC
    Lancet; 2001 Apr; 357(9264):1288-9. PubMed ID: 11421208
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis.
    Telenti A
    Thorax; 1998 Sep; 53(9):793-7. PubMed ID: 10319064
    [No Abstract]   [Full Text] [Related]  

  • 6. Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications.
    Mahomed S; Naidoo K; Dookie N; Padayatchi N
    Tuberculosis (Edinb); 2017 Dec; 107():137-143. PubMed ID: 29050762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
    Jonsson G; Furin J
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.
    Mnyambwa NP; Kim DJ; Ngadaya ES; Kazwala R; Petrucka P; Mfinanga SG
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2021-2028. PubMed ID: 28593375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalizing therapy for multidrug resistant TB: the potential of Rapid Whole Genome Sequencing.
    Bryant JM; Lipman M; Breuer J
    Expert Rev Anti Infect Ther; 2016; 14(1):1-3. PubMed ID: 26559223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A potential tool for determining drug-resistance and strain lineage.
    Chatterjee A; Nilgiriwala K; Saranath D; Rodrigues C; Mistry N
    Tuberculosis (Edinb); 2017 Dec; 107():63-72. PubMed ID: 29050774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers.
    Schito M; Dolinger DL
    EBioMedicine; 2015 Oct; 2(10):1262-5. PubMed ID: 26629499
    [No Abstract]   [Full Text] [Related]  

  • 12. Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.
    de Vos M; Ley SD; Wiggins KB; Derendinger B; Dippenaar A; Grobbelaar M; Reuter A; Dolby T; Burns S; Schito M; Engelthaler DM; Metcalfe J; Theron G; van Rie A; Posey J; Warren R; Cox H
    N Engl J Med; 2019 May; 380(22):2178-2180. PubMed ID: 31141643
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar.
    Tun T; Nyunt WW; Latt KZ; Samaranayaka A; Crump JA; Thinn KK; Cook GM; Aung HL
    Int J Mycobacteriol; 2016 Sep; 5(3):366-367. PubMed ID: 27847028
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mycobacterium tuberculosis mutants with multidrug resistance: history of origin, genetic and molecular mechanisms of resistance, and emerging challenges].
    Prozorov AA; Zaĭchikova MV; Danilenko VN
    Genetika; 2012 Jan; 48(1):5-20. PubMed ID: 22567849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine in resistant Tuberculosis: Treat the correct patient, at the correct time, with the correct drug.
    Mahomed S; Padayatchi N; Singh J; Naidoo K
    J Infect; 2019 Apr; 78(4):261-268. PubMed ID: 30849440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level.
    Velayati AA; Farnia P; Masjedi MR; Ibrahim TA; Tabarsi P; Haroun RZ; Kuan HO; Ghanavi J; Farnia P; Varahram M
    Eur Respir J; 2009 Nov; 34(5):1202-3. PubMed ID: 19880622
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidrug resistant tuberculosis.
    Amdekar YK
    Indian Pediatr; 1998 Aug; 35(8):715-8. PubMed ID: 10216564
    [No Abstract]   [Full Text] [Related]  

  • 18. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
    [No Abstract]   [Full Text] [Related]  

  • 19. Whole-genome sequencing and Mycobacterium tuberculosis: Challenges in sample preparation and sequencing data analysis.
    Dohál M; Porvazník I; Pršo K; Rasmussen EM; Solovič I; Mokrý J
    Tuberculosis (Edinb); 2020 Jul; 123():101946. PubMed ID: 32741530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
    Cox HS; Sibilia K; Feuerriegel S; Kalon S; Polonsky J; Khamraev AK; Rüsch-Gerdes S; Mills C; Niemann S
    N Engl J Med; 2008 Nov; 359(22):2398-400. PubMed ID: 19038891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.